Quick answer
This page lists 71 immunotherapy doctors in India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
About Immunotherapy doctors in India
This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.
Immunotherapy doctors
FeaturedDr. Vinod Raina
MBBS, MD (Internal Medicine), DM (Medical Oncology), Fellowship, Fellowship
Chairman – Medical Oncology · Specialty: Medical Oncologist
Fortis Memorial Research Institute Gurgaon, India40+ Years experience
Why consider this doctor?
- 40+ years of experience in Medical Oncologist
- Chairman – Medical Oncology, Fortis Memorial Research Institute, Gurugram (Present)
- Professor and Head of Medical Oncology, AIIMS, New Delhi (2001 – 2013)
Expertise & Procedures
- High-Dose Chemotherapy with Stem Cell Rescue
- Autologous Bone Marrow Transplant
- Chemotherapy (Induction, Consolidation, Maintenance)
- Concurrent Chemoradiotherapy
- Palliative Chemotherapy
Medical Oncologist Experience: 40+ YearsHospital Affiliation: Fortis Memorial Research InstituteHospital accreditation: JCI, NABH
Dr. Pooja Babbar
MBBS, MD Radiation Oncology, Senior Residency, DM Medical Oncology – Gold Medalist, European Certification in Medical Oncology (ESMO), Diploma in Medico Legal System, MBA in Hospital Management
Consultant & Unit Head – Medical Oncology · Specialty: Medical Oncologist
Fortis Hospital Manesar Gurugram, India11+ Years experience
Why consider this doctor?
- 11+ years of experience in Medical Oncologist
- Consultant & Unit Head – Medical Oncology, Fortis Hospital, Manesar, Gurugram (Present)
- American Oncology Institute, Gurugram
Expertise & Procedures
- Chemotherapy (Adjuvant, Neoadjuvant, Palliative)
- Immunotherapy (Checkpoint Inhibitors)
- Targeted Therapy (HER2, EGFR, VEGF, CDK4/6 inhibitors)
- Hormonal Therapy (Breast, Prostate cancer)
- Oncological Emergency Management
Medical Oncologist Experience: 11+ YearsHospital Affiliation: Fortis Hospital ManesarHospital accreditation: NABH, NABL, JCI
Dr. Ashok Kumar Vaid
MBBS, MD (General Medicine), DM (Medical Oncology)
Chairman — Medical Oncology, Hematology & Stem Cell Transplant · Specialty: Medical Oncologist & BMT Specialist
Medanta - The Medicity Gurgaon, India44+ Years experience
Why consider this doctor?
- 44+ years of experience in Medical Oncologist & BMT Specialist
- Chairman — Medical Oncology, Hematology & Stem Cell Transplant, Medanta – The Medicity, Gurgaon (Present)
- Pioneered one of the largest stem cell transplant programmes in private-sector north India
Expertise & Procedures
- Allogeneic Stem Cell Transplant
- Autologous Stem Cell Transplant
- Haploidentical Stem Cell Transplant
- Bone Marrow Aspiration & Biopsy
- Chemotherapy Administration
Medical Oncologist & BMT Specialist Experience: 44+ YearsHospital Affiliation: Medanta - The MedicityHospital accreditation: JCI, NABH
Dr. Imran Khan
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP — Medical Oncology
Consultant — Medical Oncology · Specialty: Medical Oncologist
Fortis Escorts Heart Institute New Delhi, India10+ Years experience
Why consider this doctor?
- 10+ years of experience in Medical Oncologist
- Consultant — Medical Oncology, Fortis Escorts, Okhla Road, New Delhi (Present)
- Associate Consultant — Medical Oncology, Fortis Escorts, Amritsar
Expertise & Procedures
- Chemotherapy Administration
- Targeted Therapy Infusions
- Immunotherapy Infusions
- PICC Line Insertion
- Bone Marrow Aspiration & Biopsy
Medical Oncologist Experience: 10+ YearsHospital Affiliation: Fortis Escorts Heart InstituteHospital accreditation: JCI, NABH
Dr. Huma Noor
MBBS, MD (General Medicine), DM (Medical Oncology), MRCP — Medical Oncology
Consultant — Medical Oncology · Specialty: Medical Oncologist
Fortis Escorts Heart Institute New Delhi, India11+ Years experience
Why consider this doctor?
- 11+ years of experience in Medical Oncologist
- Consultant — Medical Oncology, Fortis Escorts, Okhla Road, New Delhi (Present)
- Consultant — Medical Oncology, Fortis Escorts, Amritsar
Expertise & Procedures
- Chemotherapy Administration
- Immunotherapy Infusions
- Targeted & Hormonal Therapy
- Autologous Stem Cell Transplant
- Allogeneic Stem Cell Transplant (Paediatric & Adult)
Medical Oncologist Experience: 11+ YearsHospital Affiliation: Fortis Escorts Heart InstituteHospital accreditation: JCI, NABH
Dr. Dipanjan Panda
MBBS, MD (General Medicine), DM (Medical Oncology)
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Indraprastha Apollo Hospitals New Delhi, India15+ Years experience
Why consider this doctor?
- 15+ years of experience in Medical Oncologist
- Senior Consultant — Medical Oncology, Indraprastha Apollo Hospitals, New Delhi (Present)
- Associate Professor & HOD — Medical Oncology, Institute of Liver and Biliary Sciences (ILBS), New Delhi
Expertise & Procedures
- Systemic chemotherapy for solid tumours
- Targeted therapy regimens
- Immunotherapy (checkpoint inhibitors)
- Oral chemotherapy management
- Adjuvant and neo-adjuvant cancer treatment planning
Medical Oncologist Experience: 15+ YearsHospital Affiliation: Indraprastha Apollo Hospitals
Dr. Ajay Sharma
MBBS, MD, DNB, ECMO
Senior Director & Unit Head — Medical Oncology · Specialty: Medical Oncologist
BLK-Max Super Speciality Hospital New Delhi, India18+ Years experience
Why consider this doctor?
- 18+ years of experience in Medical Oncologist
- Senior Director and Unit Head, Medical Oncology — BLK-Max Super Speciality Hospital, New Delhi (Present)
- Unit Head and Senior Consultant, Medical Oncology — Rajiv Gandhi Cancer Institute and Research Centre, New Delhi (2022–2023)
Expertise & Procedures
- Adjuvant chemotherapy for solid tumours
- Neoadjuvant chemotherapy planning and delivery
- Immunotherapy and checkpoint inhibitor therapy
- Hormone therapy for breast cancer
- Molecular-targeted therapy based on biomarkers
Medical Oncologist Experience: 18+ YearsHospital Affiliation: BLK-Max Super Speciality HospitalHospital accreditation: JCI, NABH
Dr. Akshay Shah
MBBS, DNB, Fellowship in Stem Cell Transplantation
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Gleneagles Global Hospitals Mumbai, India22+ Years experience
Why consider this doctor?
- 22+ years of experience in Medical Oncologist
- Senior Consultant — Medical Oncology, Gleneagles Global Hospitals, Mumbai — Present
- Specialist in Hematology and Bone Marrow Transplantation, Gleneagles Hospitals Parel, Mumbai
Expertise & Procedures
- Allogeneic and Autologous Stem Cell Transplantation
- Bone Marrow Aspiration and Biopsy
- Intrathecal Chemotherapy Injections
- Lumbar Puncture (Spinal Tap)
- Pleurodesis
Medical Oncologist Experience: 22+ YearsHospital Affiliation: Gleneagles Global HospitalsHospital accreditation: NABH, JCI
Dr. Ankit Jain
MBBS, MRCP, MSc Oncology
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Indraprastha Apollo Hospital New Delhi, India22+ Years experience
Why consider this doctor?
- 22+ years of experience in Medical Oncologist
- Senior Consultant – Medical Oncology, Indraprastha Apollo Hospital, New Delhi, India (Present)
- Consultant Medical Oncologist, Apollo Athena Women's Cancer Centre, New Delhi, India (Present)
Expertise & Procedures
- Personalized Chemotherapy Planning
- Cancer Immunotherapy Administration
- Targeted Molecular Therapy
- Hormone Replacement Therapy for Cancer
- CAR-T Cell Therapy Coordination
Medical Oncologist Experience: 22+ YearsHospital Affiliation: Indraprastha Apollo HospitalHospital accreditation: JCI, NABH
Dr. Ankur Mudgal
MBBS, MD, DNB, Preceptorship in Immuno-Oncology
Consultant — Medical Oncology · Specialty: Medical Oncologist
Medanta - The Medicity Gurugram, India10+ Years experience
Why consider this doctor?
- 10+ years of experience in Medical Oncologist
- Consultant — Medical Oncology, Medanta – The Medicity, Gurugram, India — Present
- Over 10 years of clinical experience in medical oncology and hematological malignancies
Expertise & Procedures
- Chemotherapy Administration
- Immunotherapy and Checkpoint Inhibitor Therapy
- Targeted Molecular Therapy
- Hormone Replacement Therapy
- Palliative Chemotherapy
Medical Oncologist Experience: 10+ YearsHospital Affiliation: Medanta - The MedicityHospital accreditation: JCI, NABH
Hospitals where these doctors practise
🇮🇳 Manesar, Gurgaon, IndiaStarting from$1,000
Fortis Hospital Manesar
Est. 2013
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditationJCI — Joint Commission International accreditation
ImmunotherapyMedical OncologyCardiac SurgeryOrthopedics
1+
Doctors for Immunotherapy
4.4
74 reviews
350+
Beds
13+
Years Since Founded
🇮🇳 Gurgaon, IndiaStarting from$1,000
Medanta - The Medicity
Est. 2009
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ImmunotherapyMedical OncologyCardiac SurgeryCardiology
9+
Doctors for Immunotherapy
4.9
2150 reviews
1600+
Beds
17+
Years Since Founded
🇮🇳 New Delhi, IndiaStarting from$1,000
Fortis Escorts Heart Institute
Est. 1988
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ImmunotherapyMedical OncologyCardiac SurgeryCardiology
2+
Doctors for Immunotherapy
4.5
24 reviews
310+
Beds
38+
Years Since Founded
🇮🇳 New Delhi, IndiaStarting from$1,000
BLK-Max Super Speciality Hospital
Est. 1959
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ImmunotherapyMedical OncologyCardiac SurgeryCardiology
4+
Doctors for Immunotherapy
3.8
48 reviews
650+
Beds
67+
Years Since Founded
🇮🇳 Parel, Mumbai, IndiaStarting from$1,000
Gleneagles Global Hospitals (Global Hospitals)
Est. 1996
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationJCI — Joint Commission International accreditation
ImmunotherapyMedical OncologyLiver TransplantCardiac Surgery
5+
Doctors for Immunotherapy
4.6
183 reviews
450+
Beds
30+
Years Since Founded
🇮🇳 New Delhi, IndiaStarting from$1,000
Apollo Hospitals
Est. 1983
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ImmunotherapyMedical OncologyCardiac SurgeryCardiology
6+
Doctors for Immunotherapy
4.9
1240 reviews
1000+
Beds
43+
Years Since Founded
🇮🇳 Chennai, IndiaStarting from$1,000
Gleneagles Global Hospital
Est. 1999
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationJCI — Joint Commission International accreditation
ImmunotherapyMedical OncologyCardiac SurgeryCardiology
2+
Doctors for Immunotherapy
4.7
112 reviews
1000+
Beds
27+
Years Since Founded
🇮🇳 Gurgaon, IndiaStarting from$1,000
Fortis Memorial Research Institute
Est. 1996
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ImmunotherapyMedical OncologyCardiac SurgeryCardiology
3+
Doctors for Immunotherapy
4.8
1100 reviews
1000+
Beds
30+
Years Since Founded
Why consider treatment in India?
Many international patients consider India for liver & pancreatic cancer treatment for several reasons, including:
More affordable estimates
Competitive indicative costs compared with many other countries, for similar clinical standards.
Internationally accredited hospitals
Hospitals experienced in treating international patients.
Experienced specialists
Doctors who regularly manage similar cases.
Care coordination support
A team to help with planning, medical translation and follow-up.
About the Procedure
What is Immunotherapy?
Immunotherapy uses drugs that help the patient's own immune system recognize and destroy cancer cells, and is used across many cancers including breast, lung, colorectal, gastric/esophageal, liver/pancreatic, ovarian/gynaecological, head & neck cancers, leukemia, lymphoma, and multiple myeloma. It is given as an infusion in cycles, either alone or combined with chemotherapy/targeted therapy, and India offers globally approved immunotherapy drugs and advanced options like CAR-T cell therapy at a fraction of Western costs. Treatment plans are individualized based on tumor type, biomarker status (e.g., PD-L1, MSI), and stage of disease.
Who may be considered?
Immunotherapy may be considered after a qualified specialist reviews your reports and medical history. Suitability varies from person to person and must be assessed by your treating doctor.
How does it work?
Drugs such as PD-1/PD-L1 and CTLA-4 inhibitors are given as IV infusions every 2-4 weeks to block signals that let cancer cells evade the immune system, often combined with chemotherapy for greater effect.
3 approaches available for this procedure:
Immune Checkpoint Inhibitor Therapy
Most CommonDrugs such as PD-1/PD-L1 and CTLA-4 inhibitors are given as IV infusions every 2-4 weeks to block signals that let cancer cells evade the immune system, often combined with chemotherapy for greater effect.
Comprehensive Investigations
Estimated cost: $400 - $1,500
CBC, liver and kidney function tests, thyroid function tests, PD-L1/MSI/biomarker testing, contrast CT/PET-CT, ECG, tumor board review
Treatment / Procedure Estimate
Estimated cost in India: $1,500 - $3,500 per cycle
Stay in India
Pre-procedure stay (outside hospital): ~2-3 days
Hospitalisation: ~1 day (day-care per cycle)
Recovery period (outside hospital): ~2-3 days recommended between cycles
Total stay: approx 4-6 cycles over 3-6 months
Usually Included in Hospital Package
- Oncologist consultations
- Day-care infusion facility
- Drug administration and monitoring
- Pre-cycle blood work
- Nursing care during infusion
Usually Not Included
- Cost of immunotherapy drug (billed per cycle)
- Interim PET-CT/imaging for response assessment
- Management of immune-related side effects if hospitalization needed
- Genetic/biomarker testing not covered under package
Recovery and follow-up
Most patients tolerate immunotherapy infusions as outpatients and can resume light activity within a day or two, though fatigue, skin rash, or flu-like symptoms are common and are monitored through regular blood tests before each cycle. CAR-T patients require a longer inpatient recovery period with close monitoring for delayed immune reactions.
Risks
Immunotherapy can trigger immune-related side effects affecting the skin, gut, lungs, liver, or endocrine glands, and rarely severe reactions like cytokine release syndrome (especially with CAR-T) that require prompt hospital management. Response to treatment varies by tumor type and biomarker status, and not all patients achieve remission.
Alternatives
Depending on the cancer type and stage, alternatives include conventional chemotherapy, targeted therapy, radiation therapy, hormonal therapy, surgery, or a combination approach as advised by the tumor board.
What we need to prepare a formal estimate
Share whatever you have — the care team will confirm the final checklist after reviewing your case.
Reports required
- Histopathology and biopsy report confirming cancer type
- Biomarker/genetic testing results (PD-L1, HER2, MSI, EGFR, etc.)
- Recent CT/PET-CT/MRI imaging reports
- Complete blood count and liver/kidney function tests
- Previous chemotherapy/radiotherapy/surgery records
- Bone marrow biopsy report (for blood cancers)
- Cardiac evaluation report (ECG/ECHO)
- Discharge summaries from previous hospitalizations
Patient information needed
- Current age, weight, and general performance status
- Detailed cancer diagnosis with stage and biomarker status
- History of prior treatments and response to them
- Any known drug allergies or autoimmune conditions
- Current medications including steroids or immunosuppressants
- Presence of other chronic conditions (diabetes, heart or lung disease)
- Availability of a caregiver/attendant during treatment
- Preferred treatment start date and travel flexibility
Costs shown are indicative planning estimates based on typical pricing across leading Indian hospitals. They are not a quote — actual pricing depends on your case complexity, hospital choice, and length of stay. Share your reports for a personalized estimate.
How this directory is built
Doctors are matched using the specialty, location, condition (Immunotherapy) and procedure (Immunotherapy) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.
Need help with the next step?
Share your needs with our care coordination team for information about doctors and hospitals.
Common questions
FAQs about Immunotherapy in India
What is Liver & Pancreatic Cancer?
Liver cancer refers to malignant tumours that originate in the cells of the liver, most commonly hepatocellular carcinoma. Pancreatic cancer most frequently arises from the ductal cells of the pancreas (pancreatic ductal adenocarcinoma) and is known for its aggressive course and tendency to be detected late.
What are the symptoms and health risks of Liver & Pancreatic Cancer?
Common presentations of liver cancer include upper-right abdominal pain or fullness, unexplained weight loss, jaundice, fatigue, and abdominal swelling due to fluid accumulation (ascites). Pancreatic cancer may cause painless jaundice, mid-back or epigastric pain, new-onset diabetes, pale stools, dark urine, and significant unintentional weight loss. These symptoms overlap with many other conditions, and their presence alone is not sufficient to establish a diagnosis — a formal clinical and investigative assessment is always required.
How is Liver & Pancreatic Cancer diagnosed?
Diagnosis typically begins with blood tests including liver function panels and tumour markers such as AFP (alpha-fetoprotein) for liver cancer and CA 19-9 for pancreatic cancer, though these markers are not definitive on their own. Cross-sectional imaging — most commonly contrast-enhanced CT or MRI, and endoscopic ultrasound (EUS) for pancreatic lesions — is used to characterise the tumour and assess local spread. Staging (commonly BCLC staging for liver cancer and TNM staging for both) guides prognosis and treatment planning, and a tissue biopsy or cytological sample is usually obtained to confirm the diagnosis and tumour type.
How is Liver & Pancreatic Cancer treated?
Treatment options depend heavily on the stage at diagnosis, the patient's underlying liver function (Child-Pugh or ALBI score in liver cancer), overall fitness, and tumour biology. Surgical resection or liver transplantation may be appropriate for carefully selected liver cancer patients, while pancreatic cancer surgery (such as the Whipple procedure) is an option when the disease has not spread beyond the pancreas. For patients who are not surgical candidates, systemic therapies including chemotherapy, targeted therapy, and immunotherapy — all available through our directory — are central to management, alongside interventional options such as ablation or transarterial chemoembolisation (TACE) for liver tumours.
Can Liver & Pancreatic Cancer be treated without a procedure?
A substantial proportion of patients with liver or pancreatic cancer are managed without surgery, either because the disease is detected at a stage that precludes resection or because individual health factors make surgery high-risk. Systemic chemotherapy (for example, gemcitabine-based regimens for pancreatic cancer or sorafenib/lenvatinib for liver cancer), targeted therapy directed at specific molecular alterations, and immunotherapy with checkpoint inhibitors represent the main non-surgical treatment pillars. Palliative and supportive care — including pain management, nutritional support, and biliary stenting to relieve obstruction — is also a critical component of care for many patients and should be discussed with the treating team.
When is Immunotherapy considered for Liver & Pancreatic Cancer?
Immunotherapy may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.
Which doctor treats Liver & Pancreatic Cancer?
These cancers are typically evaluated and managed by a medical oncologist with expertise in gastrointestinal or hepatobiliary malignancies, working within a multidisciplinary team that usually includes a hepatobiliary or pancreatic surgeon, a hepatologist, an interventional radiologist, and a gastroenterologist. For liver cancer in the setting of chronic liver disease, a hepatologist often plays a central role alongside the oncology team.
How do I choose a doctor for Liver & Pancreatic Cancer?
When choosing a provider, it is advisable to look for a centre with a dedicated hepatobiliary or gastrointestinal oncology multidisciplinary tumour board, demonstrated experience with the specific cancer type, access to clinical trials, and clear protocols for ongoing monitoring and palliative support. Asking about the volume of cases managed annually and the availability of interventional radiology and advanced endoscopy on site can also help you compare facilities meaningfully.
What documents do international patients need to share for a medical evaluation?
Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.